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 Serum DL-PCB concentrations were higher in the low quality 
semen group.  
 Individual DL-PCB congeners as 77, 81,123, 126,169,118 and 
189; ∑ non-ortho and ∑ DL-PCBs could be implicated in the 
alterations of male fertility. 
 In adult men, serum dioxin-like polychlorinated biphenyls 
concentrations may have adverse effects on semen quality, with 
an increased number of morphologically abnormal sperm, 
decreased motility and sperm membrane damage. However, it 
does not appear to deteriorate sperm concentration and total 
sperm count. 
 Dioxin-like polychlorinated biphenyls seems to act, in the late 
stages of spermatogenesis (during spermiogenesis) and/or 
epididymal maturation, in adulthood. 
 
Abstract  
The relationship between dioxin-like polychlorinated biphenyl (DL˗PCB) levels 
in serum and semen parameters were investigated. Our case-control included two 
groups of patients. Total concentrations of PCBs were significantly higher in the low 
semen quality (n=24) than in the normal semen quality (n=26) group.  
A significant negative correlation was found between PCB 126 and viability in 
men with low semen quality, while PCBs 77 and 81 were positively correlated with 
morphology, and PCB 118, mono-ortho and total DL-PCBs were positively correlated 
with volume. In the normal semen quality group, PCB 189 and 118 were negatively 
correlated with sperm motility and volume, respectively. In addition, positive significant 
correlations were found between PCB 77, 23 and total non-ortho PCBs with regard to 





morphology are parameters sensitive to alteration by exposure to DL-PCBs, although 
PCB effects on spermatogenesis were not of clinical significance. 
 




Infertility is an important health problem in both the developed and developing 
worlds, with up to one in six couples requiring specialist investigation or treatments in 
order to conceive [1]. In this context, approximately 20-50% of infertility cases are 
linked to male fertility factors. In 30-40% of cases, no male-infertility-associated factor 
is found (idiopathic male infertility), with normal parameters in endocrine, genetic and 
biochemical laboratory testing [2]. However, when semen analyses are performed, a 
spermiogram reveals several sperm pathological parameters affecting fertility [3]. It has 
been hypothesised that environmental exposure to toxic pollutants and endocrine 
disruptors such as pesticides, phthalates, polychlorinated dibenzo-p-dioxins (PCDDs), 
polychlorinated dibenzofurans (PCDFs) or specifically polychlorinated biphenyls 
(PCBs) plays an important role in these trends [4].  
PCBs are persistent and lipophilic organochlorines, formerly used in cutting oils 
and lubricants and as electrical insulators. PCB use and manufacture was discontinued 
in many countries in the late 1970s in view of their toxicological effects on humans and 
laboratory animals [5]. Today, substantial exposure to PCBs persists through the 
ingestion of food, mainly fish, meat and dairy products [6]. 
Moreover, some of the PCB congeners (non-ortho and mono-ortho PCBs) 





congener of dioxins considered the most highly toxic environmental contaminant ever 
manufactured [7], and are therefore often termed “dioxin-like PCBs” (DL-PCBs). These 
compounds possess oestrogenic and anti-oestrogenic properties [8] and act through the 
cytosolic aryl hydrocarbon receptor / aryl hydrocarbon receptor nuclear translocator 
(AhR/ARNT) receptor complex, which is often called “the dioxin receptor” for this 
reason [9]. 
The male reproductive system is highly sensitive to exposure to these 
compounds [10]. Over the past 20 years several chemicals have appeared in our 
environment, and these may interfere with endogenous hormone signalling or act as 
hormones themselves, leading to steroid hormone receptor interferences [11]. Studies in 
animals have reported adverse effects involving dioxins or dioxin-like chemicals 
following both developmental exposures and exposure in adulthood, including 
reproductive defects and steroid hormone function disruption [12, 13, 14].  
However, few epidemiological studies have investigated the relationship 
between male reproductive function and DL-PCB exposure [15]. For example, Guo et 
al. showed that accidentally high prenatal exposure to PCBs/PCDFs induced alterations 
in sperm morphology, decreased sperm motility, and reduced oocyte penetration 
capacity in exposed men [16]. Dhooge et al. [17] observed in young men that semen 
volume decreased but sperm concentration increased with high levels in dioxin-like 
activity (using the “Chemical Activated LUciferase gene eXpression” or CALUX 
assay). In addition, in the large population of Russian boys aged 8-9 to 17-18, 
associations between exposures to DL-PCBs and delayed puberty were found [18].  
However, the effects of exposure at older ages are less noticeable, and 
consequently there is little epidemiologic evidence on the effects of DL-PCBs on male 





Sweden) on adult men, Toft et al. found no strong and consistent associations between 
environmental exposure to dioxin-like compounds and semen quality measurements 
using CALUX [19]. In contrast, another study found positive relationships between 
sperm quality measurements and PCBs (dioxin-like PCB-118, and non-dioxin-like 
PCBs 138, 153 and 180) in men with poor semen quality and in controls, whereas sperm 
progressive motility and concentration were inversely related to the levels of PCB 
metabolites [20]. Cross-sectional studies of men who were partners in subfertile couples 
have found inverse associations between serum concentrations of PCB 153, 138, 118, 
∑PCBs, and PCBs classified as enzyme inducers, and semen quality, particularly sperm 
motility [21, 22]. 
The aforementioned studies focus on the relationship between only one 
individual DL-PCB (PCB-118), whereas the rest are non DL-PCBs and/or congener 
groups, with seminal parameters in subfertile men. As a consequence, there is a need to 
analyse individual congeners of DL-PCBs and their potential effects on the reproduction 
system of adult men. Hence, the aim of the present study was to investigate whether the 
concentration of DL˗PCBs in serum could be correlated with semen quality in subfertile 
males. 
 
2. Materials and Methods  
2.1. Design and patients 
This investigation was designed as an analytical observational case-controlled 
study. The objects of the study were adult males (n = 56) (30-55 age range) who were 
partners in subfertile couples seeking infertility diagnosis from the IVF Spain clinic 
(Alicante, Spain) during the period from May 2012 to June 2014. Consecutive eligible 





 2.1.1. Questionnaire  
A complete clinical examination was performed on every patient, and a 
questionnaire was used to collect individual information, including personal 
background, lifestyle factors, medical history, tobacco/alcohol consumption and likely 
exposure to environmental chemical compounds. Informed consent was given by every 
patient after receiving a detailed explanation of the study. Participation of human 
subjects did not occur until written informed consent was obtained. The ethics 
committee of the University General Hospital of Alicante approved the study in 
accordance with the principles of the Declaration of Helsinki. 
2.1.2. Exclusion criteria  
Patients with known factors related to male infertility such as varicocele, post-
vasectomy or cryptorchidism, endocrine hypogonadism (abnormal hormonal 
concentrations), immune infertility, genetic disease, infection, anomalies in the 
karyotype or Y chromosome microdeletions were excluded from the study (6 out of 56 
subjects, resulting in a final n = 50).  
Finally, the patients were divided into two groups on the basis of semen quality 
according to the World Health Organization (WHO) criteria [23] as follows: (i) low 
semen quality (n = 24), composed of patients with alteration of at least one parameter in 
the semen analysis and, (ii) a control group (n = 26), composed of patients with normal 
semen quality, with all the semen parameters above the WHO 2010 cutoffs.  
2.3. Semen analysis 
 Semen samples were collected by masturbation into sterile cups following 3 
days of sexual abstinence. After 30 minutes of liquefaction at 37 ºC, standard semen 
parameters (sperm concentration, volume, percent motile sperm, and percent 





[23]. Ejaculate volumes were estimated by weighing the sample in the vessel in which it 
was collected. In order to measure sperm concentration and motility, we placed aliquots 
of semen samples (5 µL) into a prewarmed (37 ºC) Makler counting chamber (Sefi 
Medical Instruments, Haifa, Israel); a minimum of 200 sperm from at least four 
different fields were analysed from each individual sampled. Sperm motility was 
classified into four categories as follows: rapid progressive motile (Type a), slow 
progressive motile (Type b), non-progressive motile, and immotile spermatozoa. In 
addition, sperm morphology was measured on air-dried Papanicolaou-stained seminal 
smears by recording the percentage of normal forms following Kruger’s strict criteria 
[24]. Finally, the total sperm count was derived by multiplying the individual’s sperm 
concentration and volume [23]. Semen analyses were performed by the same technician, 
who was blind to other clinical data.  
2.4. Measurement of serum DL-PCBs  
Blood serum and semen samples were collected from each subject on the same 
day. Target analytes included 12 DL-PCBs from non-ortho PCBs (77, 81, 126 and 169) 
and mono-ortho PCBs (105, 114, 118, 123, 156, 157, 167 and 189). The blood samples 
were obtained by venipuncture and collected in Vacutainer test tubes without 
anticoagulant, and were immediately transferred to a glass centrifuge tube. After 
centrifugation and decantation the serums were stored in the dark at -20ºC until they 
were analysed. 
Analytical methods and quality control were carried out according to Moltó et al. 
[25]. Briefly, serum samples were spiked with ¹³C₁₂-labelled internal standards before 
extraction (WP-LCS; Wellington Laboratories Inc., Guelph, Canada), extracted several 
times using hexane, and purified using sulphuric acid. All of the reagents were for the 





were analysed by means of high-resolution gas chromatography coupled with high-
resolution mass spectrometry (HRGC/HRMS) using the isotopic dilution method in an 
Agilent HP5890 gas chromatograph equipped with a programmable temperature 
vaporisation (PTV) injector, coupled to a Micromass Autospec Ultima-NT mass 
spectrometer, using an Agilent DB5-MS chromatographic column (60 m × 0.25 mm i.d. 
× 0.25 μm).  
PCB concentrations were adjusted for total serum lipids. DL-PCB concentrations 
are reported both individually and as the sum of all congeners assayed (total DL-PCBs) 
and expressed in picograms of compound per gram of total lipids (pg/g lipid). Serum 
total cholesterol and triglycerides were measured enzymatically, and total lipid 
concentrations calculated by the Phillips formula [26]. 
The toxic equivalent units (TEQ) were then calculated based on the serum 
concentration multiplied by the respective toxic equivalent factor (TEF) according to 
WHO-TEFs-2005 [27]. We also expressed the total TEQs (total WHO-TEQ DL-PCBs) 
as the sum of the TEQs obtained from the DL-PCBs measured in the serum samples. 
Quality assurance criteria were based on the minimum requirements described in 
US EPA method 1668C for dioxin-like PCBs [28]. A procedural blank was associated 
with each batch of 4 samples and processed in the same manner.  
2.5. Statistical analyses  
The non-parametric Mann˗Whitney U˗test was used to assess differences 
between low- and normal-quality semen parameters. Multivariate linear regressions 
were used to evaluate the relationship between DL-PCB levels and semen parameters 
for both low- and normal-quality semen participants. Multivariate regression models 
were created with continuous semen parameters as dependent variables and DL-PCBs 





ortho PCBs (77, 81, 126 and 169) and mono-ortho PCBs (105, 114, 118, 123, 156, 157, 
167 and 189). In the present study, congeners below the limit of detection (LOD) were 
reported considering a concentration equal to their respective LOD. For each of the 12 
DL-PCBs measured, the percentage of samples with levels above the LOD was 
calculated. Those analytes with at least 60% of the values above the LOD were included 
in further analysis (in our study, all congeners), following early reports [31, 32]. 
Moreover, the following semen parameters (dependent variables) were included in the 
model: semen volume (mL), sperm concentration (x106/mL), sperm total count (x106), 
sperm progressive motility (%), sperm viability (%) and normal morphology (%) 
following Kruger’s criteria [24], because of relevance in the relationship between male 
reproductive function and PCB concentrations [21, 29, 30]. We considered that a 
correlation was present when we found a statistically significant linear trend between 
PCBs and the semen parameters selected. A p-value of <0.05 was considered to be 
statistically significant. Descriptive and statistical analyses were performed using SPSS 
version 17.0 (SPSS Inc., Chicago, IL, USA).  
 
3. Results 
3.1. Characteristics of participants in the study 
The characteristics of the population are described in Table 1. Participants were 
men of high and medium socioeconomic status without specific occupational exposure 
to DL-PCBs. The overall mean age and body mass index (BMI) were 38.04 ± 5.01 years 
and 24.77 ± 2.28 kg/m2, respectively (expressed as mean ± standard deviation (SD)). 
All of them were white, 84% had never smoked and 6% had never consumed alcohol. 
Non-significant differences were found in age, BMI, smoking status, alcohol and drug 





when normal and low-quality semen parameters were compared (p < 0.05). The sexual 
abstinence time was approximately 3 days; since the study design controlled for sexual 
abstinence time and this variable was not significant, there was no need to control for it 
in the analysis. 
Seminal parameter results are shown in Table 2. We found that individuals with 
low semen quality showed significant impairment of sperm concentration (24.70 ± 
33.97 x106/mL), total sperm count (38.05 ± 52.84 x106), motility (20.22 ± 23.55 %), 
viability (62.28 ± 21.93 %) and morphology (5.36 ± 4.85 %) (p < 0.001). However, 
semen volume, cholesterol and triglycerides showed similar values for both low- and 
normal-quality semen groups. 
3.2. Concentrations of PCBs  
Concentrations of PCBs expressed as pg-WHO-TEQ/g lipid in the serum 
samples are summarised in Figure 1A. The mean value of the total DL-PCBs (22.52 ± 
21.2 pg WHO-TEQ/g lipid) and the non-ortho PCBs (22.32 ± 21.33 pg WHO-TEQ/g 
lipid) in the group of patients with low quality semen were higher than in the normal 
quality semen group (14.00 ± 10.82 pg WHO-TEQ/g lipid and 13.85 ± 10.69 pg WHO-
TEQ/g lipid, respectively), but the differences were not statistically significant. 
However, mono-ortho PCBs in low semen quality patients (0.2 ± 0.13 pg WHO-TEQ/g 
lipid) were statistically higher (p ˂ 0.05) than in the control group (0.15 ± 0.13 pg 
WHO-TEQ/g lipid). 
In addition, the mean values of the DL-PCB concentrations (expressed as pg/g 
lipid) in serum of the males studied were also compared between both groups (see 
Figure 1B). We observed that individuals with altered semen parameters exhibited 
significantly higher levels of non-ortho PCBs (949.49 ± 624.97 pg/g lipid; p = 0.020) 





(508.40 ± 324.44 pg/g lipid and 4805.92 ± 2205.02 pg/g lipid, respectively). 
Furthermore, mono-ortho PCBs of subfertile patients (6080.46 ± 2754.89 pg/g lipid) 
and controls (4297.52 ± 2030.13 pg/g lipid) also tend to show significant differences (p 
˂ 0.05). 
The concentrations of each congener are listed in Table 3 in terms of mean ± 
standard deviations (SD). Results were expressed both as pg/g lipid and in terms of 
toxicity (pg WHO-TEQ/g lipid). The respective limits of detection (LOD) and p-values 
between groups can also be found in Table 3. When the concentrations of each PCB 
were compared between the two groups, we only found statistical significance for PCB 
105 (p = 0.031). Moreover, the most toxic of the DL-PCBs, PCB-126, showed a higher 
value in the low semen quality group (15.23 ± 13.83 pg WHO-TEQ/g lipid) compared 
with normal semen quality group (9.96 ± 8.14 pg WHO-TEQ/g lipid). 
PCB congeners 118, 156 and 105 were the most abundant, with mean values in 
the low semen quality and normal semen quality groups of 2695.31 vs. 1877.31 pg/g 
lipid, 1189.29 vs. 874.68 pg/g lipid and 821.13 vs. 451.38 pg/g lipid, respectively.  
 
 
3.3. Relationship between serum DL˗PCBs and sperm parameters  
For the low semen quality group, the data showed a negative significant 
correlation between PCB 126 in serum, the most toxic dioxin-like PCB, and viability (r 
= -0.645; p = 0.013). Moreover, sperm morphology was positively correlated with two 
non-ortho PCBs, PCB 77 (r = 0.671; p = 0.009) and PCB 81 (r = 0.552; p = 0.041). 
Finally, positive correlations between sperm volume and PCB 118 (r = 0.556; p = 
0.039), total mono ortho PCBs (r = 0.583; p = 0.029) and total DL-PCBs (r = 0.593; p = 





Moreover, within the normal semen quality group, corresponding positive 
correlations were significant between sperm morphology and PCB 77 (r = 0.553; p = 
0.026), PCB 123 (r = 0.559; p = 0.024) and, total non-ortho PCBs (r = 0.548; p = 
0.028). Other parameters, such as semen volume and sperm motility, showed a 
statistically significant negative correlation with PCB 118 (r = -0.539; p = 0.031) and 
PCB 189 (r = -0.521; p = 0.039), respectively (Table 5). 
When the data from the overall group (n=50) were analysed (Table 6), a 
statistically significant negative correlation of sperm progress motility (%) with PCB 
126 (r =-0.381; p = 0.037) and PCB 189 (r = -0.410; p = 0.024) was found. We also 
found a highly significant relationship between sperm viability with PCB 126 (r = -
0.557; p = 0.001), PCB 169 (r = -0.542; p = 0.002) and PCB 189 (r = -0.580; p < 
0.001). In addition, a significant negative relationship between viability and non-ortho 
PCBs (r = -0.505; p = 0.004) and the total levels of DL-PCBs (r = -0.412; p = 0.023) 
was found. Moreover, sperm morphology was positively correlated with PCB 123 (r = 
0.373; p = 0.042) but negatively correlated with PCB 189 (r = -0.440; p = 0.014). Other 
semen parameters including semen concentration, seminal volume and total sperm 
count show a lack of correlation with neither PCB concentrations. 
4. Discussion 
The present study shows tentative results on the relationship between DL-PCB 
concentrations in serum and semen quality from subfertile men. Our findings show that 
the total concentrations of PCBs were significantly higher among individuals with low 
semen quality than in normal semen quality counterparts. The WHO˗TEQ values of 
total PCBs and non-ortho PCBs were higher, although not significantly different, in 





mono-ortho PCBs in the low-quality semen group. Thus, these data show trends that are 
suggestive of a relationship between DL-PCBs and the sperm parameters evaluated.  
In comparison with early reports, we found that the total DL-PCBs value in the 
low semen quality group was similar (22.52 pg WHO˗TEQ/g lipid) to those reported 
previously in Spanish populations (20.47 pg WHO˗TEQ/g lipid) [33] and in the 
Scarlino area in Italy (21.2 pg WHO˗TEQ/g lipid) [34]. However, the values obtained in 
our study were higher than the median DL˗PCB concentrations reported in the serum 
from populations in Greece [35] and Australia [36]. 
The differences in DL˗PCB levels found among populations may be attributed to 
variations in dietary intake. In fact, the consumption of fish is likely to be the most 
relevant source of PCBs for humans [37]. In our study, the participants were from 
northern Europe, where fatty fish consumption is high [38]. In fact, Swedish and 
Finnish estimations reveal that 70–80% of the dioxin-like PCB intake originates from 
consumption of fatty fish [39]. 
We used multivariate linear regression models to assess the relationship between 
the concentration of each PCB in serum with typical sperm parameters such as motility, 
morphology, volume and viability with a view to exploring the adverse effects of PCBs 
on male fertility. For the entire group, a significantly negative correlation between 
sperm progressive motility with non-ortho PCB 126 and mono-ortho PCB 189 was 
finally observed. Further, viability was negatively correlated with non-ortho PCBs (126 
and 169), mono-ortho PCB 189 and the total PCB level. In addition, sperm morphology 
was positively correlated with PCB 123, though negatively associated with PCB 189. 
We also carried out the analysis to establish the relationship between each PCB 
and semen quality for each group of patients. In the low semen quality subgroup, we 





viability, while sperm morphology correlated positively with other individual congeners 
(non ortho PCBs 77 and 81). In the group of men with normal semen quality we found a 
statistically significant negative correlation between sperm progressive motility and 
mono-ortho PCB 189. Moreover, sperm morphology correlated positively with PCBs 77 
and 123. In this context, previous reports found a reduced motility and increased 
abnormal morphology relationship with PCB/dioxin exposure [16, 40]. However, the 
positive correlation found between the percentages of morphologically normal sperm 
with some specific congeners is contrary to the results on the effects of PCBs on sperm 
morphology previously reported [41]. The resulting variation may be due to structural 
differences between PCBs. The rate and extent of metabolism within PCBs depend on 
the number and positions of the chlorine atoms in the molecule [42]. Thus, differences 
based on the metabolism of each congener could express a variety of toxic effects on 
sperm cell biomarkers. 
In the present study, semen volume and its relationship with each PCB was also 
investigated. We found an inverse correlation with PCB 118, which reached negative 
significance only in those subjects with good sperm parameters. A similar relationship 
was found by Dhooge et al. [17] in men from the general population. In contrast, within 
the group of subjects with low semen quality, we found a positive significant 
relationship with this same congener. However, for the whole group no relationship was 
found. The effects of xenoestrogens on the endocrine system and their impact on 
reproductive health are multiple. For instance, these toxins or their metabolites may act 
directly on accessory glands by altering the quality or quantity of their secretions and 
this could influence semen volume [43]. Further studies on the effect of DL-PCB 






Interestingly, the lack of correlation between serum PCB levels and both the total 
sperm count and sperm concentration (for the entire group as well as the individual 
groups studied) was similar to those obtained in other mammals like adult male rats, in 
which exposure to TCDD at relatively high doses caused a decrease in weight of two 
androgen-sensitive organs (seminal vesicles and epididymis) without affecting 
spermatogenesis [44]. Similarly, studies performed with human adult males suggest no 
relationship between dioxin-like activity and sperm concentration [19]. By contrast, 
other authors have reported relationships between human prenatal and postnatal 
exposure to dioxin compounds and alterations in semen quality [45]. Previously, 
another study showed that exposure to low levels of these compounds before puberty 
induces a reduction in sperm concentration; however, no effects were observed during 
adulthood [46]. In a recently published study, Burns et al. analysed the association of 
peripubertal serum levels of dioxin-like compounds and non-dioxin-like PCBs with 
pubertal onset and maturity among Russian boys, who were enrolled at ages 8-9 and 
followed prospectively through ages 17-18 [18]. The authors found robust associations 
of serum levels of dioxin-like compounds with later pubertal onset and sexual maturity, 
while non dioxin-like PCBs were associated with earlier pubertal onset and sexual 
maturity. In another recent study, higher peripubertal serum TCDD concentrations and 
PCDD TEQs were associated with poorer semen parameters in young Russian men 
[47].These findings suggest that the developing male reproductive tract is particularly 
sensitive to exposure to environmental chemicals. 
In the light of those results, the level of exposure, the age at the time of exposure 
(before and after puberty), the duration of such exposure and other endogenous or 
environmental factors may play an important role on the observed effects. Furthermore, 





the mature reproductive system [46]. The impact of PCB exposure on semen quality 
appears to affect differentiation of spermatids (spermiogenesis) and epididymal 
maturation, which in turn would manifest as decreased sperm motility and morphology 
[48,49]. Epididymal and accessory gland functions are strongly regulated by sex 
hormones and express AhR, androgen receptors (AR) as well as oestrogen receptors α 
and β (ERα, ERβ) [50] as potential targets of toxic action affecting sperm motility and 
sperm DNA integrity [51]. 
Overall, several causes may contribute to the relationships observed in this study 
between DL˗PCB exposure and altered semen quality. As already mentioned, TCDD 
and other dioxin-like chemicals produce dramatic effects primarily through the aryl 
hydrocarbon receptor (AhR) according to Sorg [9]. AhR and ARNT are expressed in all 
seminiferous tubule stages of the human testes and in spermatocytes [52, 53], where 
they are thought to play an important role in normal sperm development [54]. The effect 
of AhR signalling could be stimulatory or inhibitory, depending on other factors such as 
the level of dioxin exposure, the period of sensitivity and/or development of the target 
cells, and the actual level of key regulatory molecules, including the androgen-
oestrogen balance [46]. Moreover, polymorphisms in genes involved in AhR signalling 
have also been associated with impaired semen quality [55].  
Alternatively, it is well established that dioxin compounds may produce 
oxidative stress in the male reproductive tract [56]. An increase in oxidative stress can 
be seen in approx. 80 % of clinically proven infertile men, since exposure to 
environmental toxicants is a major factor contributing to such an increase [57]. Human 
spermatozoa are particularly susceptible to oxidative stress owing to their high 
polyunsaturated fatty acid content. Although small amounts of reactive oxygen species 





lipid peroxidation with plasma membrane and mid-piece defects affecting sperm 
motility [58]. ROS can also induce oxidation of critical sulfa-hydroxyl (SH) groups in 
proteins and DNA, with direct implications for spermatogenesis and cellular 
functionality [59].  
The present study has a number of limitations. First, the number of participants included 
in the study was small. As a consequence, the results of these analyses must be 
interpreted with caution. In addition, because the study was conducted among men 
recruited through a fertility clinic, the findings of our study cannot be generalised. For a 
better understanding of the potential effects of environmental chemicals on semen 
quality, studies involving wider populations would be needed to confirm these 
preliminary findings. However, these results may still be useful to men seeking fertility 
care. 
The strengths of our study include the fact that we measured and reported not only total 
PCBs and TEQs, but also 12 individual congeners with a similar mode of action. The 
detailed congener-specific PCB analysis provides a more comprehensive and accurate 
population (or subgroups) pattern of DL-PCB exposure and represents a valuable tool to 
assist in the determination of exposure pathways for individuals. For example, highly 
chlorinated congeners such as PCBs 105, 118 and 156 were related with occupational 
exposure [60, 61]. In addition, lower chlorinated congeners may indicate indoor air 
exposure [62], while levels of non-dioxin like PCBs 153 and 180 might reflect general 
(dietary) exposures [63]. Unfortunately, we did not measure non-dioxin-like PCBs. 
Further, more detailed studies are needed to investigate dioxin-like and other PCBs –
both individual congeners and PCB mixtures – in male fertility. 
 The congener profile of DL-PCBs in serum samples could be of help in 





changes in lifestyle in order to reduce exposure to PCBs, which might improve the 
fertile capacity in infertile couples. Furthermore, construction of the toxicological 
profile of PCBs reveals the presence of several congeners that have the potential to 
affect semen quality and allows a better understanding of the 
toxicological/epidemiological consequences of exposure to hazardous substances on 
male reproductive health.  
5. Conclusions 
In summary, our findings suggest that the negative effects of dioxins occur in the 
late stages of spermatogenesis (during spermiogenesis) and/or epididymal maturation, 
resulting in the alteration of certain semen parameters such as motility, volume, 
morphology and viability. Clinicians should consider evaluating DL˗PCB congener 
profiles in the comprehensive study of male partners from couples with unexplained 
infertility even in those subjects with normal semen quality. Further studies are 
necessary in order to better understand the effects of environmental toxics on male 
reproductive health.  
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Figure 1. Comparison of the levels in serum of non-ortho, mono˗ortho and Total 
DL˗PCB concentrations expressed as pg WHO-TEQ/g lipid (A) and pg/g lipid (B) 
between normal and low quality semen groups. Mann-Whitney U-test at p<0.05 (*); not 






Table and Figure Captions 
 
Table 1. Demographic characteristics of participants in the study. 
Characteristics 
Total 
(n = 50) 
Low semen 
quality 
(n = 24) 
Normal semen 
quality 
(n = 26) 
Age (years) [Mean ± SD] 38.04±5.01 43.5±5.63 39.5±6.01 
BMI (kg/m2) [Mean ± SD] 24.77 ± 2.28 24.45±1.79 25.1±1.59 
BMI (kg/m2) [n (%)]    
˂25 38 (76%) 19 (79.2%) 19 (73%) 
25-30 12 (24.01%) 5 (20.8%) 7 (26.8%) 
Smoking status [n (%)]    
Never smoker 42 (84%) 20 (83.3%) 22 (84.6%) 
Ex-smoker 5 (10%) 2 (8.3%) 3 (11.5%) 
Current smoker 3 (6%) 2 (8.3%) 1 (3.8%) 
Drinking status [n (%)]    
Never drinker 3 (6%) 1 (4.2%) 2 (7. 7%) 
Ex-drinker 42 (84%) 20 (83.3%) 22 (84.6%) 
Current drinker 5 (10%) 3 (12.5%) 2 (7.7%) 
Drug intake [n (%)]    
Never 37 (74.2%) 17 (70.8%) 20 (76.9%) 
Ever* 13 (25.7%) 7 (29. 2%) 6 (23%) 
*Last 3 months 10 (20.8%) 6 (25 %) 4 (15.3%) 
Level of studies    
Primary education 6 (12%) 2 (8%) 4 (15%) 
High school 13 (26%) 6 (25%) 7 (26%) 
University 31 (62%) 16 (67%) 15 (58%) 
Employment status [n (%)]    
Lawyer, School, IT 42 (84%) 19 (79.2%) 23 (88.5%) 
Clerks 8 (16%) 5 (20.8%) 3 (11.5%) 
Socioecomic status [n (%)]    
High 18 (36%) 9 (37.5%) 9 (34.6%) 
Middle 30 (60%) 14 (58.3%) 16 (61.5%) 
Low 2 (4%) 1(4.2%) 1 (3.8%) 
Residential area [n (%)]    
Urban 27 (54%) 13 (54.1%) 14 (53.8%) 
Rural 23 (46%) 11 (45.8%) 12 (46.1%) 
SD: standard deviation. 
n: number of patients.  
*A total of 10% of the participants reported to be on drugs occasionally during the 













Low semen quality 
(n = 24)  
Mean ± SD 
Normal semen quality 
(n = 26) 
Mean ± SD 
pb 
Semen volume (mL) 2.48 ± 1.55 2.82 ± 0.91 0.472 
Sperm concentration (x106 /mL) 24.70 ± 33.97 73.25 ± 52.99 0.000* 
Sperm total count (x106)  38.05 ± 52.84 184.94 ± 116.33 0.000* 
Sperm progressive motility (%) 20.22 ± 23.55 59.44 ± 13.62 0.000* 
Sperm viability (%)  62.28 ± 21.93 86.81 ± 6.79 0.000* 
Normal morphology (%) 5.36 ± 4.85 13.50 ± 4.75 0.000* 
Cholesterol (mg/dL) 195.07 ± 22.96 192.75 ± 36.31 0.273 
Triglycerides (mg/dL) 133.78 ± 52.07 130.25 ± 55.22 0.972 
SD: standard deviation. 
aValues indicate n (%) 






Table 3. Concentrations of DL˗PCBs in serum (mean ± SD) in low and normal quality semen groups. 
Isomers 
Low semen quality 
(n = 24) 
Normal semen quality 
(n = 26) 
WHO-TEF 
(2005)a 
Low semen quality 
(n = 24) 
Normal semen quality 
(n = 26) 
LOD % > 
LOD 
pb 
pg/g lipid pg WHO-TEQ/g lipid pg 
no-ortho PCBs 
PCB-77 492.61 ± 519.96 222.51 ± 331.34 0.0001 0.05 ± 0.05 0.02 ± 0.03 2.9 75 0.109 
PCB-81 71.22 ± 42.09 57.49 ± 24.07 0.0003 0.02 ± 0.01 0.02 ± 0.01 3.2 70 0.294 
PCB-126 152.47 ± 138.27 99.56 ± 81.37 0.1 15.23 ± 13.83 9.95± 8.14 0.25 65 0.224 
PCB-169 233.18 ± 243.62 128.84 ± 83.48 0.03 6.99 ± 7.31 3.86 ± 2.51 0.24 83 0.147 
mono-ortho PCBs 
PCB-105 821.13 ± 506.29 451.38 ± 322.87 0.00003 0.03 ± 0.02 0.01 ± 0.01 0.24 100 0.031* 
PCB-114 189.12 ± 171.21 121.87 ± 108.36 0.00003 0.01 ± 0.01 0.01± 0.01 0.25 90 0.220 
PCB-118 2695.31 ± 1337.61 1877.31 ± 1135.20 0.00003 0.08 ± 0.04 0.06 ± 0.03 0.25 100 0.085 
PCB-123 192.28 ± 177.53 216.28 ± 419.79 0.00003 0.01 ± 0.01 0.01 ± 0.01 0.61 85 0.837 
PCB-156 1189.29 ± 786.62 874.68± 413.15 0.00003 0.04 ± 0.02 0.03 ± 0.01 0.60 100 0.195 
PCB-157 264.60 ± 163.69 228.23 ± 200.79 0.00003 0.01 ± 0.01 0.01 ± 0.01 0.65 68 0.589 
PCB-167 294.54 ± 261.99 275.31 ± 146.27 0.00003 0.01 ± 0.01 0.01 ± 0.01 0.65 94 0.810 
PCB-189 434.22 ± 392.76 252.46 ± 126.56 0.00003 0.01 ± 0.01 0.01 ± 0.04 0.21 100 0.118 
DL-PCBs 7029.96±3023.97 4805.92±2205.02  22.52±21.2 14.00±10.82    
SD: Standard deviation. 
aTEF: Toxic equivalency factors [30]  









Table 4. Multivariate regression between semen parameters and levels of DL˗PCBs for low quality semen participants. 
 Semen volume (mL)  Sperm concentration (x106 /mL)  Sperm total count (x106) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 31.172 414.240 0.096 0.743  -1.624 532.720 -0.106 0.718  -0.158 498.630 -0.016 0.957 
PCB-81 4.932 58.828 0.188 0.520  -0.035 72.103 -0.029 0.923  -0.057 73.396 -0.071 0.808 
PCB-126 41.084 49.176 0.477 0.085  -1.683 194.040 -0.413 0.142  -0.753 181.130 -0.288 0.318 
PCB-169 39.808 133.090 0.262 0.365  -1.489 269.940 -0.208 0.477  -1.109 275.380 -0.241 0.408 
PCB-105 122.320 513.590 0.388 0.171  -1.531 858.960 -0.103 0.727  -0.503 840.260 -0.052 0.859 
PCB-114 34.743 101.770 0.326 0.256  -1.175 218.150 -0.233 0.422  -0.234 198.040 -0.072 0.806 
PCB-118 462.860 1531.500 0.556 0.039*  1.579 2656.300 0.040 0.892  3.453 2563.900 0.136 0.642 
PCB-123 42.606 85.158 0.385 0.174  -1.293 224.210 -0.247 0.394  -0.478 210.470 -0.142 0.627 
PCB-156 155.580 798.130 0.318 0.269  -2.376 1248.000 -0.103 0.727  -3.750 1332.000 -0.252 0.385 
PCB-157 31.091 186.430 0.305 0.289  0.344 256.110 0.071 0.809  0.500 245.570 0.161 0.581 
PCB-167 75.936 103.610 0.465 0.094  -2.101 346.430 -0.272 0.346  -2.045 372.360 -0.412 0.143 
PCB-189 74.790 246.180 0.306 0.288  -1.994 483.490 -0.172 0.555  -1.421 488.300 -0.191 0.513 
non-ortho PCBs 117.000 655.340 0.301 0.296  -4.830 1068.800 -0.263 0.365  -2.077 1028.500 -0.176 0.548 
mono-ortho PCBs 999.930 3566.400 0.583 0.029*  -8.548 6291.600 -0.105 0.720  -4.479 6250.900 -0.086 0.770 
∑DL-PCBs 1116.900 4221.700 0.593 0.025*  -13.378 7360.400 -0.150 0.608  -6.556 7279.400 -0.115 0.697 
 Sperm progressive motility (%)  Sperm viability (%)  Normal morphology (%) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 0.416 484.210 0.019 0.949  -3.309 698.690 -0.140 0.634  71.972 107.050 0.671 0.009* 
PCB-81 0.227 66.644 0.127 0.666  0.450 43.177 0.235 0.419  4.794 45.550 0.552 0.041* 
PCB-126 -2.081 194.550 -0.354 0.214  -4.065 405.640 -0.645 0.013*  -4.165 174.780 -0.146 0.619 
PCB-169 -2.748 288.740 -0.266 0.359  -5.891 600.120 -0.530 0.051  -15.955 318.650 -0.317 0.269 
PCB-105 -1.795 857.430 -0.083 0.777  -3.680 1050.300 -0.159 0.586  45.521 577.270 0.436 0.119 
PCB-114 -1.717 223.840 -0.236 0.416  -2.165 323.980 -0.277 0.337  1.526 180.950 0.043 0.883 
PCB-118 -2.860 2753.100 -0.050 0.864  -17.566 3789.400 -0.288 0.318  -43.631 2929.000 -0.158 0.589 
PCB-123 -1.843 229.550 -0.244 0.400  -1.011 255.260 -0.125 0.670  12.638 124.580 0.345 0.227 
PCB-156 -4.379 1277.800 -0.131 0.655  -1.487 1281.900 -0.041 0.888  -33.362 1368.000 -0.206 0.481 
PCB-157 1.369 236.920 0.197 0.500  -1.557 361.600 -0.209 0.474  3.884 243.790 0.115 0.696 
PCB-167 -3.538 366.070 -0.318 0.268  -0.605 332.220 -0.051 0.863  -12.446 361.210 -0.230 0.429 
PCB-189 -3.927 513.630 -0.235 0.418  -9.422 1021.100 -0.526 0.053  -33.824 615.420 -0.417 0.138 
non-ortho PCBs -4.186 1034.100 -0.158 0.590  -12.814 1747.600 -0.450 0.107  56.646 646.040 0.439 0.116 
mono-ortho PCBs -18.689 6458.400 -0.160 0.585  -37.494 8415.800 -0.298 0.300  -59.694 6400.300 -0.105 0.721 
∑DL-PCBs -22.876 7492.500 -0.178 0.542  -50.308 10163.000 -0.365 0.200  -3.047 7046.300 -0.005 0.987 





Table 5. Multivariate regression between semen parameters and levels of DL˗PCBs for normal quality semen participants. 
 Semen volume (mL)  Sperm concentration (x106 /mL)  Sperm total count (x106) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 -24.646 292.910 -0.073 0.789  -0.444 255.010 -0.071 0.794  -0.176 255.030 -0.062 0.820 
PCB-81 -1.109 60.657 -0.045 0.869  0.031 55.254 0.067 0.805  0.013 55.078 0.063 0.817 
PCB-126 -2.249 105.980 -0.027 0.921  0.392 70.837 0.255 0.340  0.266 50.380 0.380 0.146 
PCB-169 -35.679 230.750 -0.418 0.107  0.078 123.130 0.050 0.855  -0.063 140.450 -0.087 0.747 
PCB-105 -115.070 780.040 -0.348 0.186  0.247 433.270 0.041 0.881  0.060 440.320 0.022 0.937 
PCB-114 -21.822 184.200 -0.197 0.465  -0.265 141.310 -0.130 0.632  -0.151 149.770 -0.162 0.549 
PCB-118 -626.020 3665.400 -0.539 0.031*  4.063 1579.700 0.190 0.482  1.173 1660.400 0.120 0.658 
PCB-123 -68.790 412.760 -0.160 0.553  -0.495 252.550 -0.062 0.818  -0.318 275.080 -0.088 0.746 
PCB-156 -11.972 908.880 -0.028 0.917  1.339 776.590 0.172 0.525  0.867 714.330 0.244 0.362 
PCB-157 -83.943 467.990 -0.409 0.116  1.400 125.700 0.369 0.159  0.414 151.630 0.240 0.371 
PCB-167 -4.697 288.730 -0.031 0.908  -0.497 311.720 -0.180 0.505  -0.242 320.090 -0.193 0.475 
PCB-189 12.291 217.360 0.095 0.727  0.513 214.910 0.215 0.425  0.343 189.020 0.315 0.234 
non-ortho PCBs -63.683 690.300 -0.192 0.476  0.057 504.230 0.009 0.973  0.040 500.940 0.014 0.958 
mono-ortho PCBs -920.020 6925.300 -0.443 0.086  6.304 3835.700 0.165 0.543  2.146 3900.700 0.123 0.650 
∑DL-PCBs -983.700 7615.600 -0.436 0.091  6.361 4340.000 0.153 0.572  2.186 4401.600 0.115 0.671 
 Sperm progressive motility (%)  Sperm viability (%)  Normal morphology (%) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 6.370 -156.100 0.262 0.327  11.561 -781.090 0.237 0.377  38.618 -298.840 0.553 0.026* 
PCB-81 0.220 44.406 0.125 0.646  1.260 -51.895 0.356 0.177  0.574 49.745 0.113 0.677 
PCB-126 -1.256 174.210 -0.210 0.434  -1.563 235.250 -0.131 0.630  -0.035 100.030 -0.002 0.994 
PCB-169 0.088 123.630 0.014 0.958  -1.183 231.560 -0.096 0.723  -1.732 152.230 -0.099 0.717 
PCB-105 2.992 273.570 0.126 0.641  11.653 -560.270 0.245 0.360  23.559 133.330 0.346 0.189 
PCB-114 -0.768 167.500 -0.097 0.722  2.370 -83.855 0.149 0.583  -2.187 151.390 -0.096 0.724 
PCB-118 9.405 1318.300 0.113 0.677  54.044 -2814.400 0.323 0.222  42.582 1302.500 0.178 0.509 
PCB-123 8.380 -281.780 0.272 0.308  14.170 -1013.800 0.229 0.393  49.420 -450.900 0.559 0.024* 
PCB-156 -13.256 1662.600 -0.437 0.090  -10.384 1776.100 -0.171 0.527  -23.033 1185.600 -0.265 0.322 
PCB-157 -2.420 372.050 -0.164 0.543  0.709 166.640 0.024 0.930  -2.848 266.670 -0.067 0.804 
PCB-167 0.620 238.480 0.058 0.832  3.675 -43.690 0.171 0.527  8.333 162.810 0.270 0.311 
PCB-189 -4.839 540.080 -0.521 0.039*  -8.478 988.450 -0.455 0.076  -6.190 336.020 -0.232 0.387 
non-ortho PCBs 5.422 186.150 0.228 0.396  10.074 -366.170 0.211 0.433  37.425 3.167 0.548 0.028* 
mono-ortho PCBs 0.113 4290.800 0.001 0.998  67.760 -1584.900 0.227 0.398  89.638 3087.400 0.210 0.436 
∑DL-PCBs 5.535 4476.900 0.034 0.900  77.834 -1951.000 0.240 0.371  127.060 3090.600 0.274 0.305 





Table 6. Multivariate regression between semen parameters and levels of DL˗PCBs for low and normal quality semen participants. 
 Semen volume (mL)  Sperm concentration (x106 /mL)  Sperm total count (x106) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 0.035 348.470 0.000 1.000  -1.887 444.010 -0.216 0.252  -0.843 446.720 -0.223 0.235 
PCB-81 2.346 57.574 0.090 0.636  -0.057 66.763 -0.085 0.656  -0.036 68.113 -0.126 0.508 
PCB-126 24.824 57.311 0.285 0.126  -0.374 143.150 -0.168 0.375  -0.078 133.380 -0.082 0.668 
PCB-169 11.414 146.750 0.081 0.669  -0.761 216.040 -0.213 0.259  -0.418 226.200 -0.270 0.148 
PCB-105 30.898 540.610 0.089 0.641  -1.962 723.200 -0.220 0.242  -1.028 743.590 -0.267 0.153 
PCB-114 13.952 115.630 0.127 0.505  -0.712 189.270 -0.253 0.177  -0.282 186.070 -0.232 0.217 
PCB-118 91.291 2012.900 0.092 0.627  -1.361 2327.900 -0.054 0.777  -1.333 2414.200 -0.122 0.520 
PCB-123 10.320 177.250 0.041 0.829  -0.422 226.440 -0.066 0.729  -0.139 221.240 -0.050 0.792 
PCB-156 87.002 786.890 0.180 0.340  -1.249 1084.700 -0.101 0.594  -0.762 1110.200 -0.143 0.450 
PCB-157 -5.222 259.280 -0.037 0.845  0.682 210.720 0.190 0.315  0.156 227.080 0.100 0.598 
PCB-167 49.841 149.880 0.316 0.089  -0.795 324.520 -0.197 0.296  -0.361 326.280 -0.207 0.272 
PCB-189 45.535 214.490 0.201 0.286  -0.993 387.540 -0.172 0.363  -0.453 389.980 -0.181 0.337 
non-ortho PCBs 38.620 610.100 0.095 0.619  -3.078 869.960 -0.295 0.113  -1.376 874.410 -0.306 0.100 
mono-ortho PCBs 323.620 4256.900 0.166 0.379  -6.813 5474.300 -0.137 0.470  -4.202 5618.600 -0.196 0.300 
∑DL-PCBs 362.240 4867.000 0.167 0.377  -9.891 6344.200 -0.179 0.345  -5.578 6493.000 -0.233 0.215 
 Sperm progressive motility (%)  Sperm viability (%)  Normal morphology (%) 
PCBs β1 β0 r p  β1 β0 r p  β1 β0 r p 
PCB-77 -2.718 460.350 -0.167 0.379  -5.434 758.100 -0.243 0.195  16.338 190.080 0.231 0.220 
PCB-81 -0.083 67.303 -0.067 0.727  0.103 56.175 0.060 0.752  0.722 56.900 0.134 0.481 
PCB-126 -1.583 189.360 -0.381 0.037*  -3.164 362.720 -0.557 0.001*  -3.953 162.600 -0.220 0.244 
PCB-169 -2.334 273.530 -0.350 0.058  -4.963 551.590 -0.542 0.002*  -10.365 278.080 -0.357 0.052 
PCB-105 -5.256 840.150 -0.317 0.088  -7.227 1168.600 -0.318 0.087  -0.548 629.250 -0.008 0.968 
PCB-114 -1.593 218.780 -0.304 0.103  -2.117 312.820 -0.295 0.114  -3.832 190.430 -0.168 0.374 
PCB-118 -10.894 2707.200 -0.231 0.219  -19.430 3723.400 -0.301 0.106  -42.745 2673.700 -0.209 0.268 
PCB-123 0.795 172.380 0.067 0.727  0.689 153.130 0.042 0.825  19.345 17.432 0.373 0.042* 
PCB-156 -7.478 1329.100 -0.325 0.079  -6.479 1509.800 -0.206 0.275  -32.589 1337.600 -0.326 0.078 
PCB-157 -0.350 259.610 -0.052 0.784  -1.391 350.030 -0.152 0.424  -1.747 262.150 -0.060 0.753 
PCB-167 -1.369 340.610 -0.182 0.336  -0.416 315.650 -0.040 0.832  -1.890 302.610 -0.058 0.762 
PCB-189 -4.424 519.260 -0.410 0.024*  -8.575 983.540 -0.580 0.001*  -20.616 537.250 -0.440 0.014* 
non-ortho PCBs -6.717 990.550 -0.346 0.061  -13.459 1728.600 -0.505 0.004*  2.741 687.660 0.032 0.865 
mono-ortho PCBs -30.569 6387.100 -0.330 0.075  -44.946 8517.000 -0.354 0.055  -84.622 5950.400 -0.210 0.265 
∑DL-PCBs -37.285 7377.600 -0.361 0.050  -58.405 10246.000 -0.412 0.023*  -81.880 6638.100 -0.183 0.334 
β1 indicate regression slope and β0 the intercept. Significant correlation (r Pearson) at p<0.05 (*) 
